H.E.L Group makes senior appointments as it continues to scale globally
Hasan Hallaq, PhD appointed as European Sales Director, Victoria Ordsmith joins as Director of Marketing and Sarennah Longworth-Cook promoted Director of People Appointments will help drive company growth and sales of H.E.L’s laboratory systems for the pharma, biote
Cellular Origins partners with ScaleReady to simplify, standardise, and automate cell therapy manufacturing
Cellular Origins, a TTP Company focused on enabling scalable, cost-effective and efficient manufacture of cell and gene therapies (CGTs), announces collaborative partnership with ScaleReady, a joint venture between Bio-Techne, Fresenius Kabi and Wilson Wolf that brings together process development expertise, tools and technologies for scalable CGT manufacturing. The partnership aims to automate…
Global Access Diagnostics (GADx) welcomes new leadership
Global Access Diagnostics (GADx) announces today that Mr Mark Davis is stepping down as CEO and co-founder after 20 years of unwavering service, having created the organisation Mologic Ltd in June 2003 alongside his father and industry leader, Prof. Paul Davis.
Gyros Protein Technologies introduces Gyrolab Generic Cyno ADA Kit Reagents to support pre-clinical immunogenicity assessment
Ready-to-use kit expands range of bioanalysis kits, and enables generic detection of immune complexes in cyno samples
First Patient Dosed in the US in Avacta’s AVA6000 Phase 1 Clinical Study
Avacta Group plc (AIM: AVCT), a life sciences company developing innovative, targeted oncology drugs and powerful diagnostics, announces that the first patient has been dosed in the US under its Investigational New Drug (IND) Application in Avacta’s phase 1 multi-centre trial evaluating the safet
FUJIFILM Irvine Scientific Expands BalanCD CHO Media Platform Portfolio for Bioprocessing
Chemically defined media optimized for growth and productivity of CHO cells in perfusion and batch and fed-batch bioprocesses Manufactured to cGMP-compliant standards to support production of recombinant proteins, monoclonal antibodies, and biosimilars
Avacta opens first two US Clinical Investigator sites for AVA6000 Phase 1 clinical study
Memorial Sloan Kettering Cancer Center and Fred Hutch Cancer Center now open for patient enrolment to pre|CISION™ lead programme, AVA6000
Avacta announces first patient dosed in fifth cohort of AVA6000 Phase Ia Dose Escalation Study
Avacta Group plc, a life sciences company developing innovative, targeted oncology drugs and powerful diagnostics, announces that the first patient has been dosed in the fifth cohort of the first-in-human phase I trial (ALS-6000-101) of AVA6000.
Mosaic Therapeutics closes $28m series A funding and appoints Brian Gladsden as CEO
Company developing targeted oncology therapies spun out of world-leading research at the Wellcome Sanger Institute, in collaboration with the Netherlands Cancer Institute Syncona and Cambridge Innovation Capital invested Former Novartis SVP appoint
Orbit Discovery and Evergreen Discovery collaborate to discover peptides for targeting radiopharmaceuticals
Evergreen Discovery (Evergreen), a leading radiopharmaceutical drug development company with a focus on the treatment and diagnosis of cancer, and Orbit Discovery Ltd (Orbit), a leader in the discovery of therapeutic peptide hits, announced today that they have entered into a collaboration to ide
CrestOptics launches CICERO system to provide all-in-one solution for widefield and spinning disk confocal microscopy
CrestOptics S.p.A., a manufacturer of high-end microscopy solutions and advanced systems for fluorescence microscopy and diagnostic applications, today announced the launch of its new spinning disk confocal microscope system, CICERO.
Avacta appoints Karen Harrison as Chief Operating Officer for Therapeutics Division
Avacta Group plc (AIM: AVCT), a life sciences company developing innovative, targeted oncology drugs and powerful diagnostics, today announced the appointment of Karen Harrison as Chief Operating Officer of its Therapeutics Division.
Bio-Rad Launches PTC Tempo 96 and PTC Tempo Deepwell Thermal Cyclers
Enhanced usability to support PCR applications in basic and translational research, process development, and quality control
Gyros Protein Technologies introduces new PurePep EasyClean services to accelerate development and manufacturing of peptide-based drugs
Uppsala, Sweden - Gyros Protein Technologies AB, a leading provider of peptide synthesizers and reagents, and a pioneer in automated nanoliter-scale immunoassays, announces the launch of three service offerings to support development and manufacturing of peptide-based drugs. The new services are based on the Company’s PurePep® EasyClean (PEC) orthogonal peptide purification technology.
Bio-Rad Introduces StarBright Blue and StarBright Yellow Dyes to Enhance Multiplex Flow Cytometry
StarBright Blue and StarBright Yellow Dyes Conjugated to Highly Validated Antibodies for Conventional and Full Spectrum Flow Cytometry in Immunology Research
H.E.L Group appoints Allen Wang as General Manager of H.E.L China
Appointment follows successful expansion of operations in China and transition to direct sales model Supports next phase in H.E.L’s development as China becomes significant contributor to commercial growthH.E.L Group (H.E.L), a global developer
Cytek® Biosciences Partners with Bio-Rad to Expand Reagent Portfolios
New Agreement Enhances High-Parameter Panels on Cytek Cell Analysis Systems
MIP Discovery secures significant funding to support development of global rapid response diagnostics
Funding received from the Bill & Melinda Gates Foundation for rapid deployment of novel detection reagents to support mass scale testing in low to middle-income countries.
Orbit Discovery and Endevica Bio enter multi-target collaboration to advance development of cachexia therapeutics
Orbit Discovery Limited (Orbit), a leader in the discovery of therapeutic peptide hits, today announced it has entered into a multi target Research Agreement with Endevica Bio Inc., (Endevica), a company dedicated to creating first-in-class therapeutics for cachexia caused by cancer and other chr
Bio-Rad’s CFX Opus Deepwell Dx Real-Time PCR System Advances Large Reaction Volume IVD Assay Development and Diagnostic Testing
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader in life science research and clinical diagnostic products, today announced the launch of the CFX Opus Deepwell Dx Real-Time PCR System, a real-time PCR system listed with the U.S.
Pangaea Data Named “Digital Solution of the Year” by the UK Government’s Department for International Trade (DIT)
Pangaea Data, (Pangaea), provider of a novel AI-driven product for characterizing patients by mapping their journeys and disease trajectories in a privacy-preserving and scalable manner, today announced that it has been named “Digital Solution of the Year” by the UK Government’s Department for In
Ubiquigent collaborates with University of Glasgow on translational structural biology to accelerate drug discovery within the (de)ubiquitylation field
Supporting Master’s student in Prof Helen Walden’s laboratory Project aims to determine USP30 structure to inform the design and discovery of novel inhibitorsDundee, UK - Ubiquigent Limited (Ubiquigent), a drug discovery and development compa